The 4th Chronic Kidney Disease Drug Development Summit (CKD3) is your opportunity to position your brand at the forefront of the minds of leading organizations prioritizing drug development in chronic and rare kidney diseases.
As the new era of predictive kidney organoids, robust animal models, early biomarkers of efficacy and innovative clinical trial design in clinically relevant subgroups transforms the opportunities to drive pipeline progression and expansion, ensure you are aligned with the elite experts guiding the next steps in kidney disease drug development.
We understand each business is different, so we will work with you to build a bespoke package to fulfil your business objectives and elevate your company’s influence by:
- Placing your brand in front of a qualified audience
Securing an exhibition booth to present and position your capabilities to developers who are actively seeking new solutions to optimize drug development inefficiencies
- Connecting you with the right people
Network one-to-one with stakeholders during our coordinated networking sessions to first-hand understand their requirements and present your solution
- Sharing your high-quality content
Deliver a presentation online and still be able to influence the thinking of translational and pre-clinical decision makers working to identify new promising compounds
Who Will You Meet?